OBJECTIVES: Lung cancer is the leading cause of cancer-related death worldwide. The 5-year survival rate for patients after curative surgery with pathological N0 non-small-cell lung cancer (NSCLC) is as low as 56%, which is due to recurrence and metastasis. Emerging evidence suggests that epithelial-mesenchymal transition is important for cancer metastasis. Twist and Snail are epithelial-mesenchymal transition regulators that induce metastasis by down-regulating E-cadherin. The aim of this study was to evaluate the prognostic value of Twist, Snail and E-cadherin expression in patients with resectable pathological N0 NSCLC.
Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study 
INTRODUCTION
Lung cancer is the most common malignancy in the world, and it is also the leading cause of cancer-related death [1] . This high mortality is probably attributable to early metastasis, especially for non-small-cell lung cancer (NSCLC). It has been reported that 5-year survival rate for patients after curative surgery with pathological N0 is as low as 56%, which is mainly associated with recurrence and metastasis [2] . To reduce disease-related mortality, adjuvant chemotherapy is recommended for patients with completely resected Stage II and IIIA NSCLC. However, 50% of patients with radically resected NSCLC will present with metastasis or a recurrent tumour [3] .
Tumour metastasis involves epithelial-mesenchymal transition (EMT), invasion, anoikis, angiogenesis, transport through vessels and outgrowth of secondary tumours. EMT was initially reported to be an important process in embryonic development, particularly during gastrulation and neural crest migration [4] . The term EMT describes a series of events during which epithelial cells lose many of their epithelial characteristics and acquire properties that are typical of mesenchymal cells. EMT is reported to be associated with the progression and metastasis of cancer [5] . E-cadherin, a single-span transmembrane glycoprotein, establishes homophilic interactions with adjacent E-cadherin molecules expressed by neighbouring cells, thereby forming the core of epithelial adherens junction. In human tumours, loss of E-cadherin expression is one of the hallmarks of EMT. The loss of expression can be caused by silencing of the CDH1 promoter, which can occur either by DNA hypermethylation or through the action of transcription factors such as Twist and Snail [6, 7] . Twist is a highly conserved transcription factor that belongs to the family of basic helix-loop-helix proteins that initiate mesoderm development during gastrulation [8] . Twist is a major factor responsible for metastasis of breast cancer by promoting EMT in an in vivo system, and the down-regulation of Twist is able to suppress metastatic ability by inducing mesenchymal-epithelial transition [9] . Several studies reported that TWIST-induced metastasis is associated with the down-regulation of E-cadherin [10, 11] . The transcription factor Snail, as a member of the zinc finger transcription factor family, is a mediator of EMT, because it down-regulates E-cadherin transcription and up-regulates matrix metalloproteases such as matrix metalloprotease9 [12] .
For early-stage NSCLC without nodal involvement, surgery is the preferred treatment option. However, some pathological characteristics may be associated with poor prognosis concerning long-term survival. The purpose of this study was to investigate Twist, Snail, E-cadherin and other factors associated with prognosis in recurrence-free survival (RFS) and overall survival (OS) in completely resected N0 NSCLC patients.
MATERIALS AND METHODS

Patients
A total of 78 patients with N0 NSCLC who underwent surgical resection at the Shandong Provincial Hospital Affiliated to Shandong University from 1 January 2006 to 31 December 2006 were enrolled in this study after obtaining written informed consent and approval from the Ethics and Scientific Committees of our institution. Enhanced chest computed tomography was routinely performed before surgery. Brain computed tomography or magnetic resonance imaging, upper abdomen ultrasound and whole-body bone scan were also conducted to exclude possible metastasis. Patients who had remaining macroscopic tumours or known distant metastasis were excluded from surgical treatment. All patients received complete resection of lung cancer with mediastinal lymph node dissection. The resected specimens and all dissected mediastinal lymph nodes were sent to the pathologists for pathological staging according to the 7th edition of the National Comprehensive Cancer Network (NCCN) tumour-node-metastasis (TNM) classification. Data from regular follow-up visits to the outpatient department were recorded in a database specifically designed for patients with lung cancer. A telephone inquiry was required to update the present status of all surviving patients semi-annually.
Immunohistochemistry
The specimen processing and immunohistochemistry procedures were performed as previously described [13] . Tissue sections were incubated at 4 C overnight with anti-Twist (1:400, ab50581; Abcam, Cambridge, UK), anti-Snail (1:200, ab53519; Abcam) or anti-E-cadherin (1:100, ZM-0092; ZSGB-BIO, Beijing, China). Negative controls were included by replacing primary antibodies with phosphate-buffered saline.
Evaluation of immunostaining
Under light microscopy, the tissue sections were scored semiquantitatively by staining of the membrane (E-cadherin) and the nucleus (Twist and Snail). The intensity of staining was scored as 0 (negative), 1 (weak), 2 (moderate) and 3 (strong). Scores for the percentage of positive cells were assigned as 0 (negative), 1 (1-10% positive cells), 2 (11-50% positive cells), 3 (51-80% positive cells) and 4 (>80% positive cells). The scores of each view were multiplied to give a final score of 0-12, and the final score of 1 sample was the mean of 10 microscopic fields. The final score > _4 was considered as a high-staining result [14] . The results were reviewed by 2 observers randomly blinded to patient background. The observers disagreed on 3% of the total slides. The slides with disagreement were reviewed again, and a consensus was reached.
Statistical analyses
All statistical analyses were performed using the SPSS software version 19.0 (IBM Corporation, Armonk, NY, USA). Association analysis between Twist, Snail and E-cadherin expression and the relationship between clinicopathological characteristics and protein expression were analysed with the v 2 test. OS and RFS were computed by the Kaplan-Meier method, whereas the log-rank test was used to assess statistical significance. Univariate and multivariate analyses were investigated by using the Cox proportional hazards regression model for independent prognostic value. P-values <0.05 were considered to be statistically significant. All tests were 2-tailed.
RESULTS
Patients
The 78 patients with an average age at the time of surgery of 60 years (range 23-76 years) included adenocarcinoma (n = 39), squamous cell carcinoma (n = 28), adenocarcinoma and squamous cell carcinoma (n = 7) and large-cell carcinoma (n = 4). The majority of the NSCLC patients were men (56 vs 22 women). The median follow-up time was 53 months (41.6 ± 22.4 months). Tumour recurrence or metastases developed in 34 (44%) patients at the time of the last follow-up, and 32 (41%) patients died, including 7 patients who died of other causes without a record of tumour recurrence.
Twist, Snail and E-cadherin expression in the tumour tissue
Twist protein was mainly localized in the nucleus of tumour cells, with a few cells showing localization in the cytoplasm, and Snail expression was found mainly in the cytoplasm or nucleus. On the other hand, E-cadherin expression was mainly found on the cell membrane ( Fig. 1) . Twist was not expressed homogenously throughout the whole cancer foci but was mostly limited to the invasive front (Supplementary Material, Fig. S1A ). Snail staining was preferentially observed in the marginal regions of the tumour. In addition, it was significantly expressed in stromal cells located close to cancer foci in some cases (Supplementary Material, Fig. S1B ). In some cases, we also found that cancer cells involving vascular spaces exhibited strong Snail staining (Supplementary Material, Fig. S1C ). High expression of Twist, Snail and E-cadherin were detected in 18%, 21%, and 53% of the NSCLC samples, respectively (Table 1 ), in accordance with the aforementioned criteria.
Association between patterns of Twist, Snail and E-cadherin expression and clinicopathological variables
The associations between Twist, Snail and E-cadherin expression and clinicopathological variables (age, gender, T stage, histological type, smoking history, and differentiation) are presented in Table 2 . High expression of Snail was marginally associated with the histological type of non-adenocarcinoma (P = 0.047). There was no significant association between the expression of Twist and E-cadherin and patient clinicopathological variables.
Relationship among Twist, Snail and E-cadherin
The association between Twist, Snail and E-cadherin expression was demonstrated by the v 2 test. Spearman's correlation coefficients indicated a positive association between the expression levels of Twist and Snail (P < 0.001, r = 0.51) and a negative association between the expression levels of Twist and E-cadherin (P = 0.010, r = -0.29) and Snail and E-cadherin (P = 0.032, r = -0.22).
Prognostic value of Twist, Snail and E-cadherin
In univariate analysis, age, gender and histological type were not associated with either RFS or OS. T stage showed prognostic significance for RFS (P = 0.007) and OS (P = 0.002). When considering the prognostic role of the 3 proteins, high expression of Twist and Snail and low expression of E-cadherin were prognostic factors for RFS [hazard ratio (HR) 2.29, 95% confidence interval (CI) 1.07-4.87, P = 0.026; HR 2.54, 95% CI 1.24-5.20, P = 0.008 and HR Fig. 2 ).
To avoid bias induced by stages and pathological types, we selected 59 patients with Stage T1-2a lung cancer, and these patients were subdivided into 2 groups according to their pathological type (27 patients in the squamous cell carcinoma group and 32 patients in the adenocarcinoma group). We found that Twist, Snail and E-cadherin were associated with RFS (HR 3.95, 95% CI 1.46-10.65, P = 0.003; HR 2.53, 95% CI 0.97-6.64, P = 0.047 and HR 0.09, 95% CI 0.02-0.39, P < 0.001, respectively) and OS (HR 4.73, 95% CI 1.67-13.47, P = 0.001; HR 3.02, 95% CI 1.10-8.30, P = 0.022 and HR 0.05, 95% CI 0.01-0.41, P < 0.001, respectively) in patients with squamous cell carcinoma. However, for adenocarcinoma, only Snail was associated with RFS (HR The Kaplan-Meier analysis of overall survival and recurrence-free survival for Twist (A and D), Snail (B and E) and E-cadherin (C and F). High expression of Twist/Snail and low expression of E-cadherin were associated with both shorter survival and increased recurrence.
8.99, 95% CI 2.08-38.89, P < 0.001) and OS (HR 9.88, 95% CI 2.14-45.57, P < 0.001) ( Table 3) . Then the effect of Twist, Snail and E-cadherin on local and distant recurrence was further studied. We found that Twist and Snail were associated with local recurrence (P = 0.003 and P = 0.005) and E-cadherin was associated with distant recurrence (P = 0.010) ( Table 4) .
Prognostic value of co-expression of at least 2 markers from the combination of high Twist/high Snail/low E-cadherin
The combined influence of Twist, Snail and E-cadherin expression on the prognosis of patients with pathological N0 NSCLC was also evaluated. We considered high expression of Twist or Snail or low expression of E-cadherin to be Score 1, respectively, and low expression of Twist or Snail or high expression of E-cadherin to be Score 0, respectively. According to the sum score of the 3 proteins, the patients were classified into 2 groups: Group I (Score 0-1) and Group II (Score 2-3). A difference in survival between the 2 groups was shown by univariate analysis, with Group II having a significantly poorer RFS (HR 4.12, 95% CI 2.08-8.16, P < 0.001) and OS (HR 4.28, 95% CI 2.08-8.77, P < 0.001) than Group I. This subset of patients also showed a poorer RFS (10 months vs median not reached; P < 0.001) and OS (19 months vs median not reached; P < 0.001) by the Kaplan-Meier method (Fig. 3) . In the Cox proportional hazards model, T stage (HR 2.97, 95% CI 1.36-6.46, P = 0.006) and co-expression of at least 2 markers from the combination of high Twist/high Snail/low E-cadherin expression (Score 2-3) (HR 3.99, 95% CI 1.89-8.44, P < 0.001) were significantly associated with a poorer RFS (Table 5 ). For OS, T stage (HR 3.83, 95% CI 1.61-9.12, P = 0.002) and the expression pattern of 3 proteins (Score 2-3) (HR 4.16, 95% CI 1.88-9.18, P < 0.001) were also independent prognostic factors ( Table 5) .
DISCUSSION
It is widely accepted that EMT is an essential step in tumour progression and metastasis [15] . The clinical significance of EMT has been reported in several types of human carcinomas, whereas fewer studies have evaluated EMT in NSCLC, especially pathological N0 stage [16] [17] [18] . We found that high expression of Twist and Snail, as important mediators in EMT, and low expression of E-cadherin were correlated with poor RFS and OS in patients who underwent radical surgery. The prognostic effect of Twist in lung cancer remains debatable. A recent study by Jiang et al. [19] demonstrated that high expression of Twist was found in 38% of patients and correlated with worse RFS and OS in patients with Stage I NSCLC. However, high expression of Twist was not an independent prognostic factor by a multivariate Cox regression analysis [19] . Our study reported similar results in pathological N0 NSCLC after radical resection. In addition, in the subgroup analysis of lung squamous cell carcinoma and adenocarcinoma of the T1-2a stage, we found that Twist was associated with poor prognosis in lung squamous cell carcinoma but not in lung adenocarcinoma. Our [20] showed that Twist-positive squamous cell carcinoma patients had significantly decreased survival than did Twist-negative patients. Shi et al. [14] reported no association between high expression of Twist and survival in patients with adenocarcinoma by univariate analysis. Snail, as a transcription factor, is one of the regulators of EMT and plays a key role in the development and metastasis of lung cancer. A study by Merikallio et al. [12] indicated that expression of Snail was associated with poor prognosis in squamous cell carcinoma and adenocarcinoma patients. Knockdown of Snail increased the expression of claudins 3, 4 and 7 messenger RNA in the SK-MES1 cell line, which can retard the progress of EMT [12] . In accordance with their findings, our study demonstrated that high expression of Snail was associated with poor RFS and OS in patients with pathological N0 NSCLC. In a subgroup analysis of squamous cell carcinoma and adenocarcinoma of the T1-2a stage, we found that Snail was associated with poor prognosis of squamous cell carcinoma and adenocarcinoma, respectively. Some studies using the Kaplan-Meier survival analysis found that in 2 major subgroups of squamous and adenocarcinoma, patients with low-expressed Snail had a significantly longer lifetime than patients with high Snail expression [21] . This is consistent with our findings. In another study, tissue microarray analysis of lung adenocarcinoma revealed significantly poor prognosis for patients with tumours that exhibited higher levels of Snail expression. Analysis of lung squamous cell carcinoma specimens did not reveal a significant difference in prognosis [22] . This may be because we chose different patients (Stage I vs Stage I-IV, Chinese vs American). Moreover, high expression of Snail was related to non-adenocarcinoma. Twist and Snail were proved to be poor prognostic indicators in various cancers; therefore, inhibitors of Twist/Snail could be applied clinically. Recent studies had explored some EMT interventions that could inhibit Twist/ Snail expression. For instance, entinostat was mainly studied in NSCLC and breast cancer by reversing EMT [23] , while green tea polyphenol epigallocatechin-3-gallate is as efficient as EMT inhibitor in NSCLC [24] . Targeting both receptors simultaneously may prove a more effective antitumour strategy.
E-cadherin is an important adhesion and signalling pathway mediator and plays key roles in the maintenance of tissue integrity, and the down-regulation of E-cadherin expression is one of the hallmarks of EMT. A meta-analysis by Yang et al. [25] suggested that down-regulated E-cadherin expression was significantly associated with unfavourable RFS and OS in patients with NSCLC. In our study, low expression of E-cadherin was associated with poor RFS and OS in patients with pathological N0 NSCLC. This finding highlights the value that E-cadherin has in predicting the postoperative survival of patients with lung cancer. Low E-cadherin expression was associated with high Twist expression. This observation was consistent with our previous finding demonstrating the direct regulation of E-cadherin expression by Twist [10] . One major mechanism for inhibiting E-cadherin expression is the binding of Twist [26] and Snail [27] to E-boxes in the promoter of E-cadherin to silence E-cadherin transcription.
Single expression testing of Twist/Snail/E-cadherin showed a weak prognosis value for NSCLC. A more precise method to predict the prognosis of NSCLC would be advantageous. One of the major findings in this study is that the combination of high Twist/ high Snail/low E-cadherin expression could predict poor RFS and OS in pathological N0 NSCLC. Although many different sets of markers have been studied by several groups with some success, there is little consistency between the markers [28] [29] [30] . To our knowledge, our study is the first to predict RFS and OS in pathological N0 NSCLC by using a combination of 3 EMT-related markers. This report indicated that patients with co-expression of 2 or 3 markers in the combination of high Twist/high Snail/low Ecadherin expression had a significantly worse RFS and OS compared with those with 0 or 1 marker. Co-expression of 2 or more markers in the combination was considered to be an independent prognostic factor in pathological N0 NSCLC. Our results support We considered high expression of Twist or Snail or low expression of E-cadherin to be Score 1, respectively, and low expression of Twist or Snail or high expression of E-cadherin to be Score 0, respectively. According to the sum score of the 3 proteins, the patients were classified into 2 groups: Group I (Score 0-1) and Group II (Score 2-3). Group II had a significantly poorer (A) OS and (B) RFS.
the view that staining with 3 different markers will be suitable to reach prognostic significance in pathological N0 NSCLC.
Limitations
Our study has several limitations. This is a retrospective study with a relatively small number of patients. Because there were too few specimens, some proteins such as vimentin, Slug, Zeb-1 and Zeb-2 were not included. Further research with a large sample size and in vitro study is needed.
CONCLUSION
In summary, this study demonstrated that high expression of Twist and Snail and low expression of E-cadherin were associated with unfavourable prognosis. Co-expression of at least 2 markers from the combination of high Twist/high Snail/low E-cadherin expression can predict poor RFS and OS in pathological N0 NSCLC, and it is also a marker independent of T stage. The result generated will be valuable for the diagnosis, prognosis and management of patients with pathological N0 NSCLC.
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